Business / Finance

RSS

Medifast recognized as a 2015 Future 50 Blue Chip company by SmartCEO magazine

Medifast, Inc., a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs is proud to be recognized by SmartCEO magazine as a 2015 Future 50 Blue Chip company for the fourth consecutive year.

21 Jan 2015

Nortek announces acquisition of Anthro

Nortek, Inc., a global diversified industrial company with leading brands and innovative air management and technology-driven products and solutions for residential and commercial applications, today announced it has acquired Anthro Corporation, a designer and manufacturer of technology furniture.

21 Jan 2015

Penn, Spark Therapeutics expand strategic relationship to develop treatment for progressive blindness

The University of Pennsylvania has announced an expanded relationship with Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating, genetic diseases.

21 Jan 2015

Echo Therapeutics re-establishes operational and strategic partnership with MTIA

Echo Therapeutics, Inc., a medical device company focused on skin permeation, continuous glucose monitoring, and associated technologies, announced today that it has re-established its operational and strategic partnership with Medical Technologies Innovation Asia, Ltd., Hong Kong, and has initiated the technology transfer process.

21 Jan 2015

Cohera Medical, B. Braun sign sales and distribution agreement for TissuGlu Surgical Adhesive

Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has entered into an exclusive sales and marketing distribution agreement with B. Braun for its TissuGlu Surgical Adhesive in Germany, Spain and Portugal.

From B. Braun Melsungen AG 21 Jan 2015

TPI obtains GMP certification for Qionglai Tianyin Facility

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the TPI's Qionglai Tianyin Facility (QLF) has received its Good Manufacturing Practice (GMP) certificate from the China Food & Drug Administration's (CFDA) with the GMP certification processing number: SC20140067.

20 Jan 2015

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson today announced sales of $18.3 billion for the fourth quarter of 2014, a decrease of 0.6% as compared to the fourth quarter of 2013. Operational results increased 3.9% and the negative impact of currency was 4.5%. Domestic sales increased 7.4%.

20 Jan 2015

EarlySense completes $20 million financing round

EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.

20 Jan 2015

Gecko Biomedical obtains 1.3 million euros to advance Bio-inspired Surgical Solutions

Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces today it has received 1.3 million euros from Bpifrance to advance its Bio-inspired Surgical Solutions.

20 Jan 2015

Solvanix set up to commercialise novel antibody-stabilisation technology

The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies.

17 Jan 2015

GI Partners acquires Logibec from OMERS Private Equity

GI Partners, a leading middle market private equity firm, announced today that it has completed the previously announced acquisition of Logibec, Inc., a Canadian healthcare IT company, from OMERS Private Equity.

16 Jan 2015

Signostics gets FDA 510k clearance for handheld bladder scanner

Medical device company, Signostics, announced today it has clearance from the U.S. Food and Drug Administration to launch the SignosRT Bladder, the company’s new hand-held bladder scanner.

15 Jan 2015

EKF highlighting heat and humidity compatible POC hemoglobin analyzer at Arab Health 2015

EKF Diagnostics, the global diagnostics company, announces that it will be highlighting the robustness of its new DiaSpect Tm POC hemoglobin analyzer.

From EKF Diagnostics 15 Jan 2015

Philips, Indica Labs partner to offer advanced image analysis algorithms for cancer research

Royal Philips today announced that it will further support oncology researchers' efforts to analyze pathology samples by offering advanced image analysis algorithms from Indica Labs, Inc. as part of its Digital Pathology Solutions offerings.

15 Jan 2015

CTI Life Sciences announces closing of second venture capital fund

CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.

15 Jan 2015

Vygon strengthens Asia-Pacific presence with new subsidiary in Singapore

Vygon, the specialist single-use medical devices group, today announces the opening of a subsidiary in Singapore.

15 Jan 2015

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.

14 Jan 2015

Major investment boosts Scotland's gene research

A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.

14 Jan 2015

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon Corporation, a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology, today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies.

14 Jan 2015

EvoNexus announces graduation of TruMed Systems

EvoNexus a San Diego-based incubator for technology startup companies, today announces the graduation of TruMed Systems, creators of the turnkey Vaccine Management Solution AccuVax.

13 Jan 2015